Clinical Trial Details
| Trial ID: | L5973 |
| Source ID: | NCT01441232 |
| Associated Drug: | Lx4211 |
| Title: | A Study to Evaluate the Pharmacodynamic Effects of Single-Dose Co-Administration of LX4211 With Januvia® in Type 2 Diabetics |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes Mellitus |
| Interventions: | DRUG: LX4211|DRUG: Januvia® |
| Outcome Measures: | Primary: Change from baseline in gut hormones, Days 1, 8, and 15 | Secondary: Change from baseline in fasting plasma glucose, Days 1, 8, and 15|Change from baseline in postprandial glucose, Days 1, 8, and 15|Change from baseline in insulin, Days 1, 8, and 15|Change from baseline in peptide YY, Days 1, 8, and 15|Change from baseline in urinary glucose excretion, Days 1, 8, and 15 |
| Sponsor/Collaborators: | Sponsor: Lexicon Pharmaceuticals |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE1 |
| Enrollment: | 18 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2011-10 |
| Completion Date: | |
| Results First Posted: | |
| Last Update Posted: | 2012-01-31 |
| Locations: | Lexicon Investigational Site, San Antonio, Texas, 78209, United States |
| URL: | https://clinicaltrials.gov/show/NCT01441232 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|